echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Lancet Psython: The two-way effect between COVID-19 and mental disorders

    Lancet Psython: The two-way effect between COVID-19 and mental disorders

    • Last Update: 2021-01-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    World Mental Health Day is held every year on 10 October.
    this year's World Health Day, nearly 1 billion people worldwide suffer from at least one mental disorder, according to the World Health Organization.
    to this end, WHO Director-General Tanderser said at a briefing on October 9th that the new crown pneumonia pandemic had hit the mental health of millions of people hard, underscoring the urgency of increased investment in this neglected health sector.
    mental disorders caused by COVID-19, including communication and depression, have been widely studied.
    it is not clear whether coVID-19-related risk factors can lead to mental disorders.
    , a team from the University of Oxford studied the relationship between COVID-19 and mental disorders.
    the TriNetX cohort study, researchers used data from 69 million people, 62,354 of whom were diagnosed with COVID-19.
    the researchers used tendentive scores to match the risk factors associated with controlling COVID-19 with the severity of the disease.
    the rate and risk ratio (HRs) of mental disorders, dementia, and insomnia within 14-90 days of COVID-29 diagnosis.
    to assess whether COVID-19 was associated with an increased subsequent diagnosis of mental disorders and whether patients with a history of mental disorders also had an increased risk of diagnosis of COVID-19.
    found that in patients who had no previous mental disorders, the diagnosis of COVID-19 was associated with an increased probability of first diagnosis of mental disorders in the next 14-90 days compared to the other six diseases (HR=2.1) , 95% CI 1.8-2.5 vs influenza; HR s 1.7, 95% CI 1.5-1.9 vs other respiratory infections; HR s 1. 6,95% CI 1.4-1.9 vs skin infection; 2.2,95% CI 1.9-2.6 vs Urinary stones;
    , communication, insomnia and dementia are most at risk.
    compared to the other six diseases, the K-M curve for mental disorders in patients with COVID-19 was 18.1% (95% CI 17.6-18.6%) within 14-90 days of COVID-19 diagnosis, of which 5.8% were first diagnosed.
    period, the first diagnosis of dementia in people over 65 years of age was 1.6% (95% CI 1.2-2.1%).
    , on the other hand, having a mental disorder-related diagnosis a year ago increased the risk of COVID-19 occurrence by 65%, and this increase was not related to known health-first factors.
    can not rule out the mixed disturbances that socio-economic factors may cause.
    , COVID-19 and mental disorders affect each other.
    risk of developing mental disorders in patients with COVID-19.
    , diagnosis of mental disorders increases the risk of COVID-19.
    further forward-looking queues are needed to further elaborate on the relationship between the two.
    : Taquet M, et al. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2020 Nov 9:S2215-0366 (20) 30462-4. MedSci Original Source: MedSci Original Copyright Notice: All notes on this website "Source: Metz Medical or "Source: MedSci Original" text, images and audio-visual materials, copyrighted by Metz Medical, are not authorized, and may not be reproduced by any media, website or individual, and shall be authorized to be reproduced with the words "Source: Metz Medicine".
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    reproduce content at the same time does not represent the position of this site.
    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.